Attovia Therapeutics Inc.
ATTO | NASDAQ
$21.30
-$0.84 (-3.79%)
At close: Sep 21, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 |
|---|---|---|
Cash & Equivalents | 40.19M | 30.63M |
Short-Term Investments | 112.08M | 38.69M |
Long-Term Investments | 404K | 607K |
Other Long-Term Assets | 1.33M | 393K |
Receivables | n/a | n/a |
Inventory | n/a | n/a |
Other Current Assets | 4.03M | 3.16M |
Total Current Assets | 156.3M | 72.48M |
Property-Plant & Equipment | 7.87M | 3.23M |
Goodwill & Intangibles | n/a | n/a |
Total Long-Term Assets | 9.6M | 4.23M |
Total Assets | 165.89M | 76.72M |
Account Payables | 3.55M | 4.14M |
Deferred Revenue | 450K | n/a |
Short-Term Debt | 1.92M | n/a |
Other Current Liabilities | 1.98M | 1.52M |
Total Current Liabilities | 11.01M | 7.72M |
Long-Term Debt | n/a | n/a |
Other Long-Term Liabilities | 755K | 6.87M |
Total Long-Term Liabilities | 4.1M | 6.87M |
Total Liabilities | 15.1M | 14.59M |
Total Debt | 5.26M | n/a |
Book Value | 150.79M | 62.13M |
Book Value Per Share | 3.50 | 1.44 |
Common Stock | 1K | 1K |
Retained Earnings | -111.01M | -50.38M |
Comprehensive Income | 99K | 67K |
Shareholders Equity | 150.79M | 62.13M |
Total Investments | 112.48M | 39.3M |
Add to Watchlist
Select watchlists to add or remove ATTO